Skip to content

Study in the correlation between lumbodorsal muscle function and quality of life and its application in the diagnosis and treatment of spinal deformity

Study in the correlation between lumbodorsal muscle function and quality of life and its application in the diagnosis and treatment of spinal deformity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019459
Enrollment
Unknown
Registered
2018-11-12
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Deformity

Interventions

A:Degenerative Spinal Deformity

Sponsors

The First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily participate in the test and sign the informed consent; 2. Age > 45 years old male and female; 3. At the same time,patients whose imaging parameters satisfy the coronal Cobb>10 degree and/or sagittal SVA > 5cm are included in degenerative spinal deformity group ("deformed group" for short); 4. The rest of the patients who do not meet the diagnostic criteria for degenerative spinal deformity are included in the normal control group ("control group"for short).

Exclusion criteria

Exclusion criteria: 1. Patients with cauda equina syndrome; 2. Patients with other lumbar conditions that will, in the opinion of the investigator, interfere with clinical outcomes (e.g. fresh spinal fractures, mandatory spondylitis, spinal tuberculosis, spinal infections, spinal tumors, spinal surgery history); 3. Systemic infection or other diseases that threaten life and seriously affect the quality of life; 4. Patients with cardiac pacemakers and stents, electromagnetic cochlea, aneurysm clips and other implants in the body that are not suitable for MRI examination; 5. Recent history (less than 3 years) of chemical substance dependency or significant psychosocial disturbance, which may impact the outcome or study participation; 6. Participation in a clinical trial of investigational drug or device within the past 30 days.

Design outcomes

Primary

MeasureTime frame
Maximal Isometric Strength;Peak Torque(PT);Cross-sectional area (CSA);Muscle Fat Infiltration (MFI);Oswestry Disability Index (ODI);Mos 36-item Short Form Health Survey (SF-36);

Secondary

MeasureTime frame
Time to Fatigue (TTF);Visual Analogue Scale/Score (VAS);Mean Signal Intensity (MSI);Roland-Morris Disability (RMD);Spinal Pelvic Parameters;

Countries

China

Contacts

Public ContactLuo Fei

The First Affiliated Hospital of Army Medical University, PLA

luofly1009@21cn.com+86 13883846917

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026